Predictors of Cognitive Decline and Mortality of Aged People over a 10-Year Period

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 59, Issue 3, 2004, Pages 268-274

  Tilvis, Reijo S ^a,b   Kähönen Väre, Mervi H ^a   Jolkkonen, Juha ^a   Valvanne, Jaakko ^a   Pitkala, Kaisu H ^a   Strandberg, Timo E ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E4; C REACTIVE PROTEIN; CALCIUM ION;

AGED; ALLELE; ARTICLE; CALCIUM BLOOD LEVEL; CLINICAL DEMENTIA RATING; CLINICAL EXAMINATION; COGNITIVE DEFECT; DEMENTIA; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; FINLAND; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART FAILURE; HUMAN; HYPERCALCEMIA; INTERMITTENT CLAUDICATION; LONELINESS; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; MORTALITY; POPULATION RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; RATING SCALE; RISK ASSESSMENT; SENSITIVITY ANALYSIS; STROKE; VASCULAR DISEASE;

EID: 1642275616     PISSN: 10795006     EISSN: None     Source Type: Journal    
DOI: 10.1093/gerona/59.3.m268     Document Type: Article

References (39)

1. Henderson AS, Easteal S, Jorm AF, et al. Apolipoprotein E allele epsilon4, dementia, and cognitive decline in a population sample. Lancet. 1995;346:1387-1390.
2. Evans DA, Beckett LA, Field TS, et al. Apolipoprotein E epsilon4 and incidence of Alzheimer disease in a community population of older persons. JAMA. 1997;277:822-824.
3. Hofman A, Ott A, Breteler MM, et al. Intermittent claudication, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet. 1997;349:151-154.
4. Tilvis RS, Strandberg TE, Juva K. Apolipoprotein E phenotypes, dementia and mortality in a prospective population sample. J Am Geriatr Soc. 1998;46:712-715.
5. Breteler MM, Claus JJ, Grobbee DE, Hofman A. Cardiovascular disease and distribution of cognitive function in elderly people: the Rotterdam Study. BMJ. 1994;308:1604-1608.
6. Ott A, Stolk RP, Hofman A, van Harskamp F, Grobbee DE, Breteler MM. Association of diabetes mellitus and dementia: the Rotterdam Study. Diabetologia. 1996;39:1392-1397.
7. Elias PK, Elias MF, D'Agostino RB, et al. NIDDM and blood pressure as risk factors for poor cognitive performance. The Framingham Study. Diabetes Care. 1997;20:1388-1395.
8. Leibson CL, Rocca WA, Hanson VA, et al. Risk of dementia among persons with diabetes mellitus: a population-based cohort study. Am J Epidemiol. 1997;145:301-308.
9. Curb JD, Rodriguez BL, Abbott RD, et al. Longitudinal association of vascular and Alzheimer's dementias, diabetes, and glucose tolerance. Neurology. 1999;52:971-975.
10. Ott A, Stolk RP, van Harskamp F, Pols HA, Hofman A, Breteler MM. Diabetes mellitus and the risk of dementia: the Rotterdam Study. Neurology. 1999;53:1937-1942.
11. Knopman D, Boland LL, Mosley T, et al. Cardiovascular risk factors and cognitive decline in middle-aged adults. Neurology. 2001;56:42-48.
12. Birkenhäger WH, Forette F, Seux M-L, Wang J-G, Staessen J. Blood pressure, cognitive functions, and prevention of dementias in older patients with hypertension. Arch Intern Med. 2001;161:152-156.
13. Wilkie FL, Eisdoffer C. Intelligence and blood pressure in the aged. Science. 1971;172:959-962.
14. Elias MF, Wolf PA, D'Agostino RB, Cobb J, White LR. Untreated blood pressure level is inversely related to cognitive functioning: the Framingham Study. Am J Epidemiol. 1993;138:353-364.
15. Launer LJ, Masaki K, Petrovitch H, Foley D, Havlik RJ. The association between midlife blood pressure levels and late-life cognitive function: the Honolulu-Asia Aging Study. JAMA. 1995;274:1846-1851.
16. Skoog I, Lemfelt B, Landahl S, et al. 15-year longitudinal study of blood pressure and dementia. Lancet. 1996;347:1141-1145.
17. Glynn RJ, Beckett LA, Hebert LE, Morris MC, Scherr PA, Evans DA. Current and remote blood pressure and cognitive decline. JAMA. 1999;281:438-445.
18. Tzourio C, Dufouil C, Ducimetiere P, Alperovitch A. Cognitive decline in individuals with high blood pressure: a longitudinal study in the elderly. EVA Study Group Epidemiology of Vascular Aging. Neurology. 1999;53:1948-1952.
19. Kivipelto M, Helkala E-L, Laakso MP, et al. Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study. BMJ. 2001;322:1447-1451.
20. Guo Z, Viitanen M, Fratiglioni L, Winbald B. Low blood pressure and dementia in elderly people: the Kungsholmen project. BMJ. 1996;312:805-808.
21. Zhu L, Viitanen M, Guo Z, Winblad B, Fratiglioni L. Blood pressure reduction, cardiovascular diseases, and cognitive decline in the Mini-Mental State Examination in a community population of normal very old people: a three-year follow-up. J Clin Epidemiol. 1998;51:385-391.
22. Ruitenberg A, Skoog I, Ott A, et al. Blood pressure and risk of dementia: results from the Rotterdam Study and the Gothenburg H-70 Study. Dement Geriatr Cogn Disord. 2001;12:33-39.
23. Notkola IL, Sulkava R, Pekkanen J, et al. Serum total cholesterol, apolipoprotein E epsilon4 allele, and Alzheimer's disease. Neuroepidemiology. 1998;17:14-20.
24. Muldoon MF, Flort JD, Ryan CM. Serum cholesterol, the brain, and cognitive functioning. In: Waldstein SR, Elias MF, eds. Neuropsychology of Cardiovascular Disease. Mahwah, New Jersey: Lawrence Erlbaum Associates, Publishers; 2001:37-59.
25. Tilvis RS, Hakala SM, Valvanne J, Erkinjuntti T. Postural hypotension and dizziness in a general aged population: a four-year follow-up of Helsinki Aging Study. J Am Geriatr Soc. 1996;44:809-814.
26. Folstein MF, Folstein SE. "Mini-Mental State." A practical method for grading the cognitive state of patients for the clinician. J Psychiat Res. 1975;12:189-198.
27. Hughes CP, Berg L, Danziger WL, Coben LA, Martin R. A new clinical scale for staging of dementia. Br J Psychiatr. 1982;140:566-572.
28. Sorva A, Valvanne J, Tilvis R. Serum ionized calcium and the prevalence of primary hyperparathyroidism in age cohorts of 75, 80 and 85 years. J Intern Med. 1992;231:309-312.
29. Ehnholm C, Lukka M, Kuusi T, Nikkilä E, Utermann G. Apolipoprotein E polymorphism in the Finnish population: gene frequencies and relation to lipoprotein concentrations. J Lipid Res. 1986;27:227-235.
30. Strandberg TE, Tilvis RS. C-reactive protein, cardiovascular risk factors and mortality in a prospective study in the elderly. Arterioscler Thromb Vasc Biol. 2000;20:1057-1060.
31. Dixon WJ. BMDP [Biomedical Data Processing System] Statistical Software. London: University of California Press; 1988.
32. Strandberg TE, Valvanne J, Erkinjuntti T, Sorva A, Tilvis RS. Serum lipids, health, and one-year mortality in randomized age cohorts of 75, 80, and 85 years: the Helsinki Aging Study. Nutr Metal Cardiovasc Dis. 1992;2:101-105.
33. Tilvis RS, Pitkala KH, Jolkkonen J, Strandberg TE. Social networks and dementia. Lancet. 2000;356:77-78.
34. Fratiglioni L, Wang HX, Ericsson K, Maytan M, Winblad B. Influence of social network on occurrence of dementia: a community-based longitudinal study. Lancet. 2000;355:1315-1319.
35. Clarke M, Clarke SJ, Jagger C. Social intervention in the elderly: a randomized controlled trial. Am J Epidemiol. 1992;136:1517-1523.
36. Maier H, Smith J. Psychological predictors of mortality in old age. J Gerontol. 1999;54B:P44-P54.
37. Landfield PW, Thibault O, Mazzanti ML, Porter NM, Kerr DS. Mechanisms of neuronal death in brain aging and Alzheimer's disease: role of endocrine-mediated calcium dyshomeostasis. J Neurobiol. 1992;23:1247-1260.
38. Forette F, Seux M-L, Staessen JA, et al. The prevention of dementia with antihypertensive treatment. Arch Intern Med. 2002;162:2046-2052.
39. Burney RE, Jones KR, Christy B, Thompson NW Health status improvement after surgical correction of primary hyperparathyroidism in patients with high and low preoperative calcium levels. Surgery. 1999;125:608-614.